Clinical trials using glutamine to prevent toxicity from chemotherapy
Author (Ref.) . | n a . | Chemotherapy . | Glutamine dose (po) . | Results . |
---|---|---|---|---|
Rubio (10) | 9 | MTXb | 0.5 g/kg/day | No mucositis seen |
Skubitz (19) | 14 | varied | 4 g BID × 28 days | Decreased stomatitis |
Savarese (7) | 5 | paclitaxelc | 10 g TID × 4 days | Prevention of myalgias/arthralgias |
Ohkuno (16) | 66 | 5FU | 4 g BID × 14 days | No difference in mucositis from controls |
Author (Ref.) . | n a . | Chemotherapy . | Glutamine dose (po) . | Results . |
---|---|---|---|---|
Rubio (10) | 9 | MTXb | 0.5 g/kg/day | No mucositis seen |
Skubitz (19) | 14 | varied | 4 g BID × 28 days | Decreased stomatitis |
Savarese (7) | 5 | paclitaxelc | 10 g TID × 4 days | Prevention of myalgias/arthralgias |
Ohkuno (16) | 66 | 5FU | 4 g BID × 14 days | No difference in mucositis from controls |